Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate | Zendy

AI Assistant Blog Pricing

Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.